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Abstract
Background: Early occurrence of immunosuppression is a risk factor for infected pancreatic necrosis (IPN) in the
patients with acute pancreatitis (AP). However, current measures for the immune systems are too cumbersome and
not widely available. Significantly decreased lymphocyte count has been shown in patients with severe but not
mild type of AP. Whereas, the correlation between the absolute lymphocyte count and IPN is still unknown. We
conduct this study to reveal the exact relationship between early lymphocyte count and the development of IPN in
the population of AP patients.
Methods: One hundred and fifty-three patients with acute pancreatitis admitted to Jinling Hospital during the
period of January 2012 to July 2014 were included in this retrospective study. The absolute lymphocyte count and
other relevant parameters were measured on admission. The diagnosis of IPN was based on the definition of the
revised Atlanta classification.
Results: Patients were divided into two groups according to the presence of IPN. Thirty patients developed infected
necrotizing pancreatitis during the disease course. The absolute lymphocyte count in patients with IPN was
significantly lower on admission (0.62 × 109/L, interquartile range [IQR]: 0.46–0.87 × 109/L vs. 0.91 × 109/L, IQR:
0.72–1.27 × 109/L, p < 0.001) and throughout the whole clinical course than those without IPN. Logistic regression
indicated that reduced lymphocyte count was an independent risk factor for IPN. The optimal cut-offs from ROC curve
was 0.66 × 109/L giving sensitivity of 83.7 % and specificity of 66.7 %.
Conclusions: Reduced lymphocyte count within 48 h of AP onset is significantly and independently associated with
the development of IPN.
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Background
Acute pancreatitis (AP) is a sudden inflammation of the
pancreas with a mortality rate of 6–10 % [1]. In the past,
the Atlanta classification was commonly used to grade
the severity of AP, briefly, mild and severe AP. Patients
with severe acute pancreatitis (SAP) are usually associ-
ated with multiple organ dysfunction (MODS) and poor
prognosis. About 5–10 % of the AP patients would de-
velop necrosis of the pancreatic or peripancreatic tissue
[2] and the necrotic tissue can remain sterile or be in-
fected, becoming infected pancreatic necrosis (IPN). IPN
is known to be an independent risk factor for ultimate
mortality [3] and always develops during the second or
third week after the onset of the disease [4, 5]. It is re-
cently reported that more than 80 % of the mortality oc-
curs at the late stage as a result of infection [6]. Thus, it
is of great importance to distinguish those patients with
higher risk for IPN at the initial stage of the disease and
make preventive intervention.
Recently, more and more studies have shown that im-
munosuppression is a key pathogenesis of SAP. Early al-
terations of the immune system comprising decreased
activation of T lymphocyte [7] and down regulation of
human leukocyte antigen (HLA) DR [8] may cause IPN,
leading to multiple organ failure (MOF) and high mor-
tality. In this way, these immunological indexes might be
useful predictors for the prognosis of AP patients.
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However, due to the complexity of the measurement
methods, the abovementioned indexes are not moni-
tored routinely in the clinical work. Recently, the
prognostic value of the neutrophil-lymphocyte ratio
(NLR) had also been evaluated, but turned out with
controversial results [9]. The absolute lymphocyte
count was also assessed as an important part of the
immune system. In 1985, Christophi et al. first de-
clared the absolute lymphocyte count had a prognos-
tic significance in the severity of acute pancreatitis
[10]. Whereas, no further studies regarding the role
of the absolute lymphocyte count as an independent
factor for disease severity or mortality in AP patients
were carried out after that [11].
Our investigation was the first study to compare the
early alteration of the absolute lymphocyte count in the
peripheral blood of AP patients with and without IPN.
The aim of this study was to determine whether the
lymphocyte count was a strong predictor for IPN in
patients with acute pancreatitis and how strongly the ab-




This was a retrospective observational study conducted
in the Department of General Surgery, Jinling Hospital,
China. The data collection for this study was approved
by the Institutional Review Board of our hospital. One
hundred fifty-three patients with a diagnosis of acute
pancreatitis consecutively treated in our center during
January 2012 to July 2014 were included for potential
analysis. The diagnostic criteria of AP were according to
two of the following three clinical features [2]: upper ab-
dominal pain, significantly increased serum levels of lip-
ase (or amylase) activity and imaging findings consistent
with acute pancreatitis. The inclusion criteria were AP
patients aged 18 years or older who admitted to our cen-
ter within 48 h after the onset of the disease and re-
ceived systemic laboratory evaluations on admission.
Patients during pregnancy, with a history of cancer or
bone marrow diseases or a medical history of immuno-
suppressive agents were excluded from this study.
Data collection
All the patients with AP were evaluated for blood rou-
tine and biochemical tests at arrival in the central la-
boratory of our hospital. Hemoglobin, hematocrit,
platelet, C-reactive protein (CRP), white blood cells as
well as the absolute neutrophil and lymphocyte counts
were obtained from an automatic blood cell analyzer
(CELL-DYN3700, Chicago, Abbott). NLR was calculated
using the values of the absolute neutrophil and lympho-
cyte counts. Serum levels of albumin, amylase and lipase
were detected using an Aeroset (Hitachi 7060 Automatic
Biochemical Analyzer, Tokyo, Japan). HLA-DR and T
lymphocyte subsets were also assayed in our central la-
boratory in 30 patients (24 in non-IPN group and 6 in
IPN group) by the direct fluorescence method for the
whole blood using flow cytometer in a flow cytometer
(FACS-Calibur, Becton Dickinson, San Jose, Calif., USA)
and double straining (FITC/PE) monoclonal antibodies
(Marseilles, France). HLA-DR expression was measured
in the monocyte population and T lymphocyte subsets
were measured in the lymphocytes population. Analysis
of the data was performed by CellQuest software. Demo-
graphic variables, possible etiology of acute pancreatitis
were reviewed and recorded by two independent
physicians.
Baseline characteristics, including age, gender, body
mass index, Acute Physiology and Chronic Health
Enquiry II (APACHE II) score and computed tomography
(CT) severity index, were also collected and recorded.
Definition
The diagnosis of IPN was according to the imaging find-
ings and/or bacterial culture result: either the presence
of extraluminal gas in the pancreatic and/or peripan-
creatic tissues on contrast-enhanced computed tomog-
raphy (CECT) or positive bacterial culture of aspiration
and drainage content of pancreatic and/or peripancreatic
tissues could confirm the diagnosis [2]. Lymphocytope-
nia was defined as the absolute lymphocyte count below
0.8 × 109/L. Organ dysfunction was evaluated in three
organ systems (respiratory, renal and cardiovascular)
within 24 h after admission and the definition of organ
dysfunction was based on the modified Marshall scoring
system, defining as a score of 2 or more [12]. The defin-
ition of local complications, including portal vein throm-
bosis, intra-abdominal hypertension and hemorrhage,
deep vein thrombosis (DVT) and gastrointestinal fistula,
judged by two independent physicians, was according to
the recently revised Atlanta criteria [2]. Disease severity
of AP was assessed based on the presence of sterile/
infected pancreatic necrosis and transient/persistent
organ failure, namely, mild, moderate, severe and
critical AP [13].
Statistic analysis
Continuous variables in the data were presented as
medians plus interquartile range (IQR) and categorical
variables were presented as absolute numbers and per-
centage. Mann–Whitney U test was used in continuous
variables and Chi-square test was used to analyze cat-
egorical variables for group comparisons. Logistic regres-
sion was constructed to evaluate the relationship
between the relevant parameters and secondary infec-
tion. Multivariate logistic regression only involved in the
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variables that showed statistic significance in univariate
analysis. Further receiver operating characteristic (ROC)
curve was displayed for accuracy assessment. Statistical
analyses were performed using SPSS (version 22.0) stat-
istical software (IBM Analytics, Armonk, NY). A prob-
ability (p value) of <0.05 was considered statistically
significant.
Results
1096 patients were initially screened for the study and
eventually 153 patients were enrolled for analysis (Fig. 1).
Patients were divided into two groups according to the
presence of IPN, namely, IPN (n = 30) and non-IPN
(n = 123) group. Except for the acute physiology and
chronic health enquiry II (APACHE II) score, the
baseline characteristics showed no significant differ-
ences between the two groups (Table 1). Also, no sig-
nificant difference was seen in the distribution of
etiology. Lymphocytopenia developed in 42 (34.1 %)
patients in non-IPN group and 19 (63.3 %) patients
in IPN group (p = 0.006). The median absolute
lymphocyte count in peripheral blood of the patients
with IPN was significantly lower than those patients
without IPN on admission (0.62 × 109/L, interquartile
range [IQR]: 0.46–0.87 × 109/L vs. 0.91 × 109/L, IQR:
0.72–1.27 × 109/L, p < 0.001) and also in the following
days (Fig. 2). Consistent with the previous studies, the
median value of NLR was significantly higher in the
patients with IPN compared to those without (15.5,
IQR: 12.0–23.8 vs. 10.9, IQR: 7.7–18.2, p = 0.002), in-
dicating immunosuppression occurred at the very
onset of AP in the patients with IPN. As for other
immunological indexes, we also measured the expres-
sion of HLA-DR on peripheral monocytes and T
lymphocyte subsets on peripheral lymphocytes. Down-
regulated expression of HLA-DR (15.5 %, IQR: 12.9–
31.7 % vs. 30.3 %, IQR: 22.4–51.9 %, p = 0.026) and
decreased proportion of mature T lymphocytes
(44.8 %, IQR: 31.4–51.5 % vs. 51.5 %, IQR: 40.4–
63.9 %, p = 0.203) in the patients with IPN also con-
firmed the presence of immunosuppression (Fig. 3).
As a result of immunosuppression, patients who de-
veloped IPN suffered higher mortality and longer hos-
pital durations.
Table 2 represented the comparison of complications
and outcome between the two groups. The incidence of
organ dysfunction was 30.9 % (38/123) in the patients of
non-IPN group and 86.7 % (26/30) in those of IPN
group (p < 0.001). Acute respiratory distress syndrome
(ARDS) and acute kidney injury (AKI) were two most
common organ dysfunctions in both groups, followed by
shock, mainly septic shock. Higher percentage of organ
dysfunctions in the patients with IPN led to increased
need for mechanical ventilation and continuous renal re-
placement therapy (CRRT). Intra-abdominal hemorrhage
and hypertension were the most common complications
in both two groups, followed by fistula. Four patients in
the non-IPN group died during hospitalization: MOF for
two patients, pulmonary embolism and unexplained car-
diac arrest for the remaining two patients, respectively.
The hospital mortality was much higher in the patients
with IPN, above 40 %. All patients but one died of MOF.
Fig. 1 Screening and grouping of the study patients
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Table 1 Baseline characteristics and clinical features of the AP patients with or without IPN
Variable Non-IPN group (n = 123) IPN group (n = 30) p Value
Age, years 45 (36, 56) 47 (38, 57) 0.529
Gender, male/female 79/44 21/9 0.068
BMI 26.1 (23.3, 28.8) 27.3 (23.0, 28.4) 0.155
APACHE II score 13 (12, 15) 20 (14, 29) <0.001
CT severity index 3 (3, 6) 8 (6, 8.5) <0.001
Laboratory data
Hemoglobin, g/L 135 (116, 150) 126 (101, 149) 0.247
Hematocrit 0.40 (0.34, 0.45) 0.36 (0.29, 0.44) 0.211
Platelet, ×109/L 158 (117, 204) 116 (81, 166) 0.002
CRP, mg/L 161.0 (71.8, 208.8) 202.7 (158.7, 251.5) 0.001
WBC, ×109/L 13.0 (9.6, 17.3) 11.8 (8.7, 14.6) 0.152
Lymphocyte count, ×109/L 0.91 (0.72, 1.27) 0.62 (0.46, 0.87) <0.001
NLR 10.9 (7.7, 18.2) 15.5 (12.0, 23.8) 0.002
Albumin, g/L 35.6 (34.0, 38.2) 34.4 (31.6, 36.2) 0.010
Amylase, U/L 276 (138, 544) 270 (183, 934) 0.129
Lipase, U/L 1095 (457, 1916) 972 (579, 1814) 0.963
Aetiology of acute pancreatitis, no. (%)
Gallstone 59 (48.0) 14 (46.7) 1.000
Hypertriglyceridemia 49 (39.8) 15 (50.0) 0.409
Alcohol 11 (8.9) 1 (3.3) 0.462
Post-ERCP 2 (1.6) 0 (0) 1.000
Other 2 (1.6) 0 (0) 1.000
AP acute pancreatitis, IPN infected pancreatic necrosis, BMI Body Mass Index, APACHE II score Acute Physiology and Chronic Health Enquiry II score, CT computed
tomography, CRP C-reactive protein, WBC white blood cells, NLR Neutrophil-lymphocyte ratio, ERCP Endoscopic Retrograde Cholangiopancreatography
Fig. 2 Change of the absolute lymphocyte count during the disease
course of acute pancreatitis in the patients of different groups. Values
were presented with median ± interquartile range (IQR); IPN: infected
pancreatic necrosis. *p < 0.05 for IPN vs. non-IPN group, **p < 0.001 for
IPN vs. non-IPN group
Fig. 3 Change of Human leukocyte antigen (HLA)-DR and T
lymphocyte subsets in patients of different groups. Values were
presented with median ± IQR; IPN: infected pancreatic necrosis.
*p < 0.05 for IPN vs. non-IPN group, **p < 0.001 for IPN vs.
non-IPN group
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Univariate logistic regression analysis (Table 3) was per-
formed to evaluate the predictive power of the absolute
lymphocyte count, NLR and other related parameters for
IPN. Results indicated significant correlations between IPN
and APACHEII score, platelet, CRP, lymphocyte count,
NLR, albumin as well as amylase. Further stepwise multi-
variate logistic regression was constructed and displayed in
Table 4. The final model suggested that APACHEII score
(Odds Ratio: 1.299, 95 % confidence interval [CI]: 1.153–
1.464, p < 0.001) and reduced lymphocyte count (Odds
Ratio: 0.006, 95 % CI: 1.153–1.464, p < 0.001) were strongly
and independently associated with IPN. The area under the
ROC curve (Fig. 4) showed the reduced absolute lympho-
cyte count (0.842, 95 % CI: 0.769–0.914, p < 0.001)
had a moderate to high accuracy in predicting IPN,
higher than APACHEII score (0.819, 95 % CI: 0.722–
0.917, p < 0.001). The optimal cut-offs from ROC
curve was 0.66 × 109/L giving sensitivity of 83.7 % and
specificity of 66.7 %.
Discussion
About one third of the patients with necrotizing pan-
creatitis would develop IPN progressively [14]. IPN
would prolong the hospital stay and increase the inci-
dence of complications as well as mortality. Briefly,
the development of IPN determines the management
of acute pancreatitis and has a great influence on the
prognosis. In accordance with previous studies, the
incidence of complications and mortality were much
higher in the patients with IPN than those without.
Also, MOF caused by pancreatic infection or sepsis
was the major death cause in both two groups.
Hence, it is urgent to find a simple and early marker
that could predict IPN at the very onset of the dis-
ease. In the literature, several biochemical parameters
such as procalcitonin, CRP and NLR have been inves-
tigated but turned out with unsatisfying results. Our
study first assessed the predictive power of the abso-
lute lymphocyte count for IPN in the patients with
acute pancreatitis and demonstrated that the absolute
lymphocyte count was a strong predictor for IPN in
AP patients with a moderate to high accuracy. Pa-
tients who developed IPN in the late course of AP
had significantly lower lymphocyte count in the per-
ipheral blood at the initial stage (within 48 h of AP
onset) than those without IPN. Contrast to the study
Table 2 Complications and outcomes of the AP patients with or without IPN
Non-IPN group (n = 123) IPN group (n = 30) p Value
Severity of AP, no. (%) <0.001
Mild 59 (48.0) 0 (0)
Moderate 26 (21.1) 0 (0)
Severe 38 (30.9) 4 (13.3)
Critical 0 (0) 26 (86.7)
Organ dysfunction, no. (%)
Respiratory 34 (27.6) 19 (63.3) <0.001
Renal 20 (16.3) 22 (73.3) <0.001
Cardiovascular 5 (4.1) 12 (40.0) <0.001
Mechanical ventilation, no. (%) 21 (17.1) 18 (60.0) <0.001
CRRT, no. (%) 20 (16.3) 19 (63.3) <0.001
Complication, no. (%)
Pancreatic pseudocyst 8 (6.5) 1 (3.3) 1.000
Invasive fungal infection 0 (0) 2 (6.7) 0.037
Intra-abdominal hemorrhage 1 (0.8) 9 (30.0) <0.001
Deep vein thrombosis 5 (4.1) 2 (6.7) 0.624
Portal thrombosis 1 (0.8) 1 (3.3) 0.355
IAH 6 (4.9) 8 (26.7) 0.001
Encephalopathy 1 (0.8) 0 (0) 1.000
Fistula 0 (0) 5 (16.7) <0.001
Hospital stay, days 10 (6, 14) 30 (18, 54) <0.001
ICU stay, days 6 (3, 9) 17 (9, 48) <0.001
Mortality rate, no. (%) 4 (3.3) 13 (43.3) <0.001
IPN infected pancreatic necrosis, AP acute pancreatitis, CRRT continuous renal replacement therapy, IAH intra-abdominal hypertension, ICU intensive care unit
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of Azab et al., our study indicated that NLR did not
show good prognostic value when compared with
lymphocyte count [15]. However, in Azab et al.’s
study, the primary outcome was severity instead of
secondary infection, which might contribute to the
difference of the results in the two studies.
Currently, immunosuppression is well accepted as an
important risk factor for IPN in AP patients [8]. HLA-
DR is a crucial immunological index and shows close re-
lationship with sepsis and late mortality in SAP patients
in many studies [16–18]. Early alteration of T lympho-
cyte subsets is also proved to have significant influence
on the prognosis of AP patients [19]. Nonetheless, those
immunological indexes need to be examined by flow
cytometry, which are not routinely performed in every
hospital due to its high cost and complexity. Further-
more, the accuracy of flow cytometer largely depends on
the laboratory technician who carried out the
experiment.
The absolute lymphocyte count, as a simple im-
munological index, can roughly and rapidly reflect the
general change of the immune system. More import-
antly, the lymphocyte count can be easily assessed
and is available in every hospital. Christophi et al.
first evaluated the prognostic value of the absolute
lymphocyte count in 104 male patients and 50 female
patients with acute pancreatitis. They classified the
patients according to their severities, mild and severe
group. They found that the mean absolute lymphocyte
count in the patients with SAP was significantly lower
than those with mild AP and concluded that the ab-
solute lymphocyte count had an accurate predictive
power for AP severity. However, major flaws in that
study were as follows: First, the patients included in
that study were not restricted to those in the acute
phase. Second, the results of the statistic analysis
were not powerful enough to get such a solid conclu-
sion. More recently, a study performed by Conlledo
et al. confirmed that early lymphocyte count was
Table 3 Univariate logistic regression analysis for IPN
Elements Odds ratio 95 % Confidence Interval p Value
Age 1.005 0.977–1.034 0.734
Gender 0.447 0.199–1.006 0.052
BMI 1.105 0.942–1.296 0.218
APACHE II score 1.288 1.168–1.421 <0.001
Hemoglobin 0.991 0.976–1.006 0.221
Hematocrit 0.025 0.000–5.185 0.175
Platelet 0.988 0.981–0.996 0.002
CRP 1.010 1.004–1.017 0.001
WBC 0.941 0.865–1.023 0.153
Lymphocyte count 0.020 0.003–0.123 <0.001
NLR 1.059 1.015–1.104 0.008
Albumin 0.858 0.762–0.967 0.012
Amylase 1.001 1.000–1.001 0.034
Lipase 1.000 1.000–1.000 0.750
HLA-DR 0.909 0.806–1.025 0.120
CD3+ T cell 0.945 0.872–1.025 0.173
CD4+ T cell 0.944 0.844–1.055 0.310
CD8+ T cell 0.930 0.807–1.071 0.312
CD4+/CD8+ T cell 0.953 0.254–3.580 0.944
IPN infected pancreatic necrosis, BMI Body Mass Index, APACHE II score Acute
Physiology and Chronic Health Enquiry II score, CRP C-reactive protein, WBC
white blood cells, NLR Neutrophil-lymphocyte ratio, ERCP Endoscopic Retrograde
Cholangiopancreatography, HLA-DR human leukocyte antigen-DR
Table 4 Multivariate stepwise logistical regression and receiver operator characteristic (ROC) curve to predict IPN
Element Odds Ratio (95 % CI) p Value AUROC (95 % CI) p Value
Lymphocyte count 0.006 (0.000–0.100) <0.001 0.842 (0.769–0.914) <0.001
APACHE II score 1.299 (1.153–1.464) <0.001 0.819 (0.722–0.917) <0.001
ROC receiver operator characteristic, IPN infected pancreatic necrosis, AUROC area under receiver operating characteristic curve, CI confidence interval, APACHE II
score Acute Physiology and Chronic Health Enquiry II score
Fig. 4 Receiver operating characteristic (ROC) curve for the absolute
lymphocyte count in predicting infected pancreatic necrosis (IPN)
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independently associated with increased mortality in
patients with sepsis or septic shock [20]. Besides, the
study also indicated that the absolute lymphocyte
count was closely associated with late infection.
One latest retrospective study by Zeng et al. identified
the independent risk factors for pancreatic infection in
163 patients with acute pancreatitis [11]. They per-
formed multiple logistic analyses and concluded that in-
creased lactate dehydrogenase (LDH), high CT severity
index, delayed fluid resuscitation and hypoxemia were
independent risk factors for predicting IPN in patients
with SAP. Nonetheless, they did not integrate the abso-
lute lymphocyte count into their analysis.
Circulating lymphocyte subsets in acute pancreatitis
have also been studied for a long time in the literature
[21]. Many studies suggested that dysregulation of T
lymphocytes played a vital role in the process of acute
pancreatitis [22, 23] and down regulation of HLA-DR in-
dicated IPN development and poor prognosis [16, 24].
In our patients, significantly down-regulated HLA-DR
was also seen in those AP patients with IPN. However,
the relationship between HLA-DR and IPN was not
strong enough, probably attributing to the limited sam-
ple size. Similar to previous studies [19], the percentage
of mature T lymphocyte was also a bit lower in the pa-
tients with IPN, as well as the percentages of CD 4+ and
CD8+ T lymphocytes. These results demonstrated that
the occurrence of immunosuppression at the early stage
of acute pancreatitis might be a strong independent risk
factor for IPN development in the late stage. To verify
this hypothesis, further larger studies might be needed.
Several limitations of our study were listed as follows:
Firstly, because of the small number of the IPN patients,
the predictive power might be slightly influenced. Sec-
ondly, the retrospective nature of the study limited the
extension of the study. Lastly, there were some data
missing in the respect of HLA-DR and T lymphocyte
subsets, which may also have some influence over the
results. However, the majority of the abovementioned
limitations were not thought to have too much influence
on the results as they were equally existed in the two
groups.
Conclusion
In summary, early immunosuppression always occurs in
AP patients who might develop IPN in the late stage of
the disease. Reduced lymphocyte count at the initial
stage of the disease (within 48 h of AP onset), which
simply and generally reflects the dysfunction of the im-
mune system, might be an early and powerful predictor
for IPN in AP patients.
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